PP
TMO icon

Paloma Partners’s Thermo Fisher Scientific TMO Stock Holding History

Paloma Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,400
Closed -$774K – 1670
2024
Q2 		$774K Sell
1,400
-3,737
-73% -$2.14M 0.02% 587
2024
Q1 		$2.99M Sell
5,137
-2,363
-32% -$1.33M 0.16% 156
2023
Q4 		$3.98M Sell
7,500
-300
-4% -$145K 0.15% 150
2023
Q3 		$3.95M Buy
7,800
+3,900
+100% +$2.08M 0.14% 134
2023
Q2 		$2.03M Buy
+3,900
New +$2.1M 0.07% 241
2023
Q1 		– Sell
-2,400
Closed -$1.32M – 978
2022
Q4 		$1.32M Buy
+2,400
New +$1.27M 0.06% 306
2022
Q2 		– Sell
-19,000
Closed -$11.2M – 1746
2022
Q1 		$11.2M Buy
+19,000
New +$10.9M 0.33% 35
2021
Q3 		– Sell
-4,400
Closed -$2.22M – 1860
2021
Q2 		$2.22M Buy
4,400
+900
+26% +$425K 0.04% 399
2021
Q1 		$1.6M Sell
3,500
-1,700
-33% -$811K 0.03% 502
2020
Q4 		$2.42M Sell
5,200
-3,600
-41% -$1.69M 0.06% 320
2020
Q3 		$3.88M Buy
+8,800
New +$3.64M 0.1% 195
2019
Q2 		– Sell
-2,500
Closed -$684K – 2171
2019
Q1 		$684K Buy
+2,500
New +$622K 0.02% 916
2018
Q4 		– Sell
-33,200
Closed -$8.1M – 1762
2018
Q3 		$8.1M Buy
+33,200
New +$7.64M 0.15% 99
2018
Q2 		– Sell
-15,800
Closed -$3.26M – 2193
2018
Q1 		$3.26M Buy
+15,800
New +$3.32M 0.05% 329
2017
Q4 		– Sell
-41,200
Closed -$7.79M – 2299
2017
Q3 		$7.79M Sell
41,200
-25,300
-38% -$4.58M 0.11% 167
2017
Q2 		$11.6M Buy
+66,500
New +$11.2M 0.14% 100

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Paloma Partners's TMO Position: Q4 2024 in Review

Paloma Partners sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 1,300 shares — an estimated $804K sold.

Paloma Partners first reported a position in TMO in Q2 2013 and held it in 32 quarters. The position peaked at $18.4M in Q1 2021. 2,616 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • Paloma Partners reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 1,300 Thermo Fisher Scientific shares in Q4 2024, an estimated $804K.
  • Paloma Partners first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 32 quarters.
  • Paloma Partners's Thermo Fisher Scientific position peaked at $18.4M in Q1 2021.
  • 2,616 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.